Article ; Online: The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas.
Journal of the American Society of Nephrology : JASN
2023 Volume 34, Issue 11, Page(s) 1793–1811
Abstract: Abstract: The interaction between the kidney and the coagulation system greatly affects each other because of the abundant vessel distribution and blood perfusion in the kidney. Clinically, the risks of complicated thrombosis and bleeding have become ... ...
Abstract | Abstract: The interaction between the kidney and the coagulation system greatly affects each other because of the abundant vessel distribution and blood perfusion in the kidney. Clinically, the risks of complicated thrombosis and bleeding have become important concerns in the treatment of nephropathies, especially nephrotic syndrome, CKD, ESKD, and patients with nephropathy undergoing RRTs. Adverse effects of anticoagulant or procoagulant therapies in patients with nephropathy, especially anticoagulation-related nephropathy, heparin-induced thrombocytopenia, and bleeding, seriously worsen the prognosis of patients, which have become challenges for clinicians. Over the decades, the interaction between the kidney and the coagulation system has been widely studied. However, the effects of the kidney on the coagulation system have not been systematically investigated. Although some coagulation-related proteins and signaling pathways have been shown to improve coagulation abnormalities while avoiding additional kidney damage in certain kidney diseases, their potential as anticoagulation targets in nephropathy requires further investigation. Here, we review the progression of research on the crosstalk between the coagulation system and kidney diseases and systematically analyze the significance and shortcomings of previous studies to provide new sight into future research. In addition, we highlight the status of clinical treatment for coagulation disorder and nephropathy caused by each other, indicating guidance for the formulation of therapeutic strategies or drug development. |
---|---|
MeSH term(s) | Humans ; Blood Coagulation Disorders/complications ; Blood Coagulation Disorders/drug therapy ; Anticoagulants/adverse effects ; Kidney ; Nephrotic Syndrome/drug therapy ; Thrombosis/complications ; Blood Coagulation Factors ; Hemorrhage ; Heparin/adverse effects |
Chemical Substances | Anticoagulants ; Blood Coagulation Factors ; Heparin (9005-49-6) |
Language | English |
Publishing date | 2023-07-24 |
Publishing country | United States |
Document type | Review ; Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 1085942-1 |
ISSN | 1533-3450 ; 1046-6673 |
ISSN (online) | 1533-3450 |
ISSN | 1046-6673 |
DOI | 10.1681/ASN.0000000000000199 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3344: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.